| Chen KF, Yu HC, Liu TH, et al.
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation. [JOURNAL ARTICLE]
J Hepatol 2009 Oct 23.
Abstract | Full Citation | Find Related Articles | | Pasello G, Favaretto A
Molecular Targets in Malignant Pleural Mesothelioma Treatment. [JOURNAL ARTICLE]
Curr Drug Targets 2009 Dec 1.
Abstract | Full Citation | Find Related Articles | | Monaghan K, Khong T, Smith G, et al.
CYT997 Causes apoptosis in human multiple myeloma. [JOURNAL ARTICLE]
Invest New Drugs 2009 Nov 12.
Abstract | Full Citation | Find Related Articles | | Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full Citation | | Finn JD, Hui D, Downey HD, et al.
Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction. [JOURNAL ARTICLE]
Mol Ther 2009 Nov 10.
Abstract | Full Citation | | O'Connor OA, Stewart AK, Vallone M, et al.
A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | | Brunvand MW, Bitter M
Amyloidosis relapsing after autologous stem cell transplantation treated with Bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant. [JOURNAL ARTICLE]
Haematologica 2009 Nov 10.
Full Citation | | Neznanov N, Gorbachev AV, Neznanova L, et al.
Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications. [JOURNAL ARTICLE]
Cell Cycle 2009 Dec 25; 8(23)
Abstract | Full Citation | Find Related Articles | | Koreth J, Alyea EP, Murphy WJ, et al.
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review. [Journal Article, Research Support, N.I.H., Extramural]
Biol Blood Marrow Transplant 2009 Dec; 15(12):1502-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Minarik J, Scudla V, Bacovsky J, et al.
Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma. [Journal Article]
Neoplasma 2010; 57(1):8-14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |    |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
